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ABSTRACT
Public health surveillance is the ongoing systematic
collection, analysis and interpretation of data, closely
integrated with the timely dissemination of the resulting
information to those responsible for preventing and
controlling disease and injury. With the rapid
development of data science, encompassing big data and
artificial intelligence, and with the exponential growth of
accessible and highly heterogeneous health-related data,
from healthcare providers to user-generated online
content, the field of surveillance and health monitoring is
changing rapidly. It is, therefore, the right time for a short
glossary of key terms in public health surveillance, with an
emphasis on new data-science developments in the field.
PURPOSE OF THIS GLOSSARY
‘Only describe, don’t explain’, attributed to Ludwig
Wittgenstein
Public health surveillance is the ongoing systema-
tic collection, analysis and interpretation of data,
closely integrated with the timely dissemination of
the resulting information to those responsible for
preventing and controlling disease and injury.1 It is
a core element of public health practice, through
routine monitoring and reporting systems, and of
population health science—the science that informs
public health and prevention strategies—through
observational evidence.2 More specifically, surveil-
lance aims to provide health decision-makers with
timely and useful information to set priorities, to
identify the need for interventions and to evaluate
the effects of interventions.3 It is related to public
health research but differs in its purposes (figure 1):
research aims to increase general knowledge while
surveillance aims to provide information for deci-
sion and action in public health.1
With, on the one hand, the rapid development
of data science, encompassing big data and arti-
ficial intelligence (AI), and, on the other hand,
the exponential growth of accessible and highly
heterogeneous health-related data, from electro-
nic medical records used by healthcare providers
to user-generated online content,4-6 the field of
surveillance and health monitoring is changing
rapidly with a widening scope of application, an
increasing depth and new methods. It is,
therefore, the right time for a glossary for public
health surveillance and monitoring, with an
emphasis on new data-science developments.7
We do not aim to cover the whole field of sur-
veillance but rather focus on how data science is
changing methods and concepts, going from data
generation and collection to information dissemi-
nation for decision-making (figure 2).
ABERRATION DETECTION
In public health, aberration detection is the identifi-
cation of anomalous events or patterns in data, with
a clinical or public health potential relevance, that is,
statistical signals in surveillance data that may be of
epidemiological importance.8 A major challenge, of
growing importance with the use of highly hetero-
genous types of surveillance data, is to account for
random variability and measurement error, which
makes it difficult to tease out the ‘signal’ uponwhich
the decision to intervene is based from the ‘back-
ground’ noise.9 Traditionally, outbreak detection
and infectious disease surveillance have relied on
reports from clinicians and laboratories. At the
turn of the century, surveillance expanded to con-
sider prediagnostic or syndromic data, such as the
Figure 1 Health data and related information are
used, on one hand, to increase general knowledge,
which corresponds traditionally to a public health
research activity. On the other hand, they are also key
for guiding decisions and actions by stakeholders in
public health, which corresponds to public health sur-
veillance activities. The knowledge produced by
research is eventually used to improve public health
surveillance.
Figure 2 Steps in the data processing of public health surveillance, from data generation and collection to information
dissemination for decision-making.
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count of patients visiting an emergency room5 (see also
Syndromic surveillance). With the growth in volume and variety
of accessible surveillance data, aberration detection methods
have evolved from the analysis of time series of case counts to
the complex modelling of individual-level surveillance cases with
covariates drawn from multiple sources5,8; it is also applied
beyond the field of human infectious diseases.
BIG DATA AND DATA SCIENCE
Big data refers to the massive amount of data that is more andmore
easily accessible through the digitalisation of all aspects of health,
healthcare and related areas.10 It is characterised by its variety,
volume and velocity—the ‘3Vs’.11 Multiple sources of data have
become usable for public health surveillance, for example, mobile
phones, online searches, social media, credit card transactions,
wearable and ambient sensors, electronic health records (EHRs),
medico-administrative records and pharmacy sales. While public
health monitoring relies traditionally on well-defined and high-
quality data, effective use of big data for surveillance requires new
analytical methods such as data mining and data visualisation; data
science is becomingmainstream in public health, integrating knowl-
edge and skills from informatics and biostatistics. One major chal-
lenge in the analysis of big data is to account for the low quality, the
poor data consistency across setting and time and the lack of meta-
data (see also Source population and selectivity bias). The question-
able ‘veracity’ (the fourth ‘V’) of big data refers actually to its poor
quality and high noise. Of critical importance is to go from big to
‘smart’ data, that is, data that can be transformed into information.
While the development of big data and related data-science meth-
ods opens the way to data-informed or data-driven healthcare and
public health,12 it also raises major concerns about privacy protec-
tion (see also Ethics of public health surveillance and privacy protec-
tion). At the policy level, the use of big data for surveillance raises
issues of access and benefit sharing, accountability and transparency
and quality and safety.13,14
DATA, INFORMATION, KNOWLEDGE AND WISDOM PYRAMID
The data, information, knowledge and wisdom (DIKW) pyramid is
a framework to help understand the hierarchal relationships from
data to wisdom.15 It has gained importance in public health mon-
itoring, with the growing use of all types of data for surveillance
activities, notably to highlight that data do not speak by itself and
need to be transformed to become information, for example, in the
form of health indicators,16,17 with the latter having to be contex-
tualised to become knowledge and eventually wisdom, for example,
to inform health policy decisions18 (see also figure 2). The DIKW
pyramid also highlights that surveillance is not the mere collection
and analysis of data, but a complex multilayer activity at the core of
public health decision-making process, allowing evidence-informed
policy-making19 (see also Evidence based and data-informed public
health). Recently, it has been proposed to review this pyramid, by
deemphasising the notion of wisdom and by adding ‘evidence’
between information and knowledge (DIEK)20; evidence emerges
through the comparison of information and is used to build action-
able knowledge for public health.
DATA MINING
The discovery of patterns in large data sets by drawing on a range of
methods from engineering, computer science and statistics is called
data mining (see also Big data and data science). These methods are
applied in an automated or semiautomated manner, usually with no
a priori specification of the pattern to be detected. In a health mon-
itoring context, somemethods used for detecting aberrations or out-
breaks can be considered data mining methods5 (see also Aberration
detection). Mining EHRs aims to gather information from unstruc-
tured narrative data21 (see also Electronic medical record).
DATA VISUALISATION
Data visualisation has always been an important tool of public health
surveillance. However, with the growth in available data and the
improvement in statistical tools, data exploration through visualisa-
tion has gained importance for surveillance andmonitoring activities.
The fieldhas evolvedwithcontributionsof computer sciencemerging
scientific visualisation, information visualisation and visual analytics,
making visualisation an important part of surveillance data
analyses22; it is a powerful tool to understand complex multilayer
data,which are not easily capturedby simple indicators. It has amajor
impact on how temporal and spatial analyses are conducted and
reported. The production of continuously updated maps and atlas
of diseases and risk factorshasbecomepossible by leveragingbigdata,
thereby strengthening the surveillance of numerous conditions, nota-
bly of infectious diseases.23 Visualisation of healthcare outputs
through maps has also become a standard tool for health services
research aiming to address unwarranted variation in healthcare.24
Data visualisation is also gaining importance for displaying complex
longitudinal data from EHRs25 (see also Electronic medical record).
One major change is the possibility of tailoring visualisation surveil-
lance output to users’ needs through interactive data visualisation.22
ETHICS OF PUBLIC HEALTH SURVEILLANCE AND PRIVACY
PROTECTION
In 2017, the WHO issued international ethics guidelines on public
health surveillance.26,27 Surveillance activities raise ethical issues due
to data collection methods, notably when the identity of individuals
is recorded. More broadly, it is necessary to account for the balance
between the protection of privacy and the benefits at a population
level. With the development of surveillance based on the analyses of
medicoadministrative,6 social media or geospatial mobile phone
data, and with growing linkage possibilities, individual privacy pro-
tection has become a major concern. The increasing sophistication
and broadening possibilities for data linkage put at risk data manage-
ment transparency and accountability.13,14 The newEuropeanUnion
General Data Protection Regulation (GDPR) is the current legal
framework for the collection of personal data in European
countries18; it aims notably to give citizens more control over their
own data and to harmonise data protection across Europe. The
broad principles of GDPR include having a legitimate basis for data
collection, purpose limitation, transparency, as much privacy and
data minimisation as possible and accountability for all data use.18
ELECTRONIC MEDICAL (EMR) OR HEALTH RECORD (EHR) AND
PERSONAL HEALTH RECORD (PHR)
The increasing adoption of electronic records to manage medical
and health data creates new opportunities for public health
monitoring.28 An electronic medical record (EMR) is used to
integrate, manage and analyse patient data collected in a clinical
context, often within one clinic or institution. An EHR is
intended to have a broader scope, encompassing all health-
related data over the life course. A related concept is a personal
health record (PHR), which is an EHR controlled by a patient. In
all cases, these records are useful for population monitoring to
the extent that they record concepts and health events in
a consistent and unambiguous manner (eg, through the use of
data standards and ontology29), which enables different systems
to exchange data, or interoperate30 (See also Interoperability).
Major challenges remain such as how to define the denominators
for events extracted from EHR.31
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EVIDENCE-BASED AND DATA-INFORMED PUBLIC HEALTH
At the crossroad between population health science2 and applied
public health research, public health surveillance is a core ele-
ment of evidence-based public health (figure 3).32 Indeed, popu-
lation assessment, production of indicators and reports and
evaluations are typical activities and outcomes of public health
surveillance. Monitoring the literature is also an integral part of
surveillance, for example, to allow comparison and benchmark-
ing or to challenge measurement and definition of indicators. In
the age of data science, the management of surveillance data and
information has gained importance in the evidence-based public
heath cycle, with the policy-making process becoming not only
evidence based but also data informed if not data driven.
Evidence-based public health should also guide how surveillance
system is designed33 (see also Population health record).
FORECASTING
Data collected through surveillance are often analysed to identify
important changes in population health. Inference about change
requires an estimate of the expected state of population health,
which is obtained through forecasting, or predicting future popu-
lation health status using data collected in the past. Many meth-
ods are available for forecasting, from a simple average of
historical values to multivariate time-series methods.34
Forecasting of expected values is a critical step in routine surveil-
lance for outbreaks and is also used to estimate the future burden
from chronic diseases and other prevalent conditions. The accu-
racy of a forecast usually decreases as the length of the horizon
increases and is usually evaluated by comparing forecasts to
actual values once data become available. Because the perfor-
mance of predictive models depends on the quality and stability
(across eg, time and space) of data, forecasting methods must
adapt to the relatively low quality and selectivity of big data (see
also Source population and selectivity bias).
INTEROPERABILITY
Increasingly, public health surveillance draws data from a wide
range of sources and makes information available to many stake-
holders. This acquisition of data and dissemination of information
has traditionally been a manual process, but as volumes continue
to grow, automation of data and information exchange becomes
necessary. Such automation requires the definition and adoption
of standards that indicate clearly how information systems should
interact with one another or interoperate. The term semantic
interoperability is used to define the ability for one information
system to receive data from another system and to reliably process
this data to produce information.35 For example, messaging
standards such as Health Level Seven and Fast healthcare
Interoperability Resource allow public health surveillance systems
to interoperate with laboratory systems and information exchange
standards such as Statistical Data and Metadata Exchange allow
public health systems to interoperate with web-based systems to
automate the dissemination of population-based indicators.
MACHINE LEARNING, ARTIFICIAL INTELLIGENCE
AI can be defined in terms of human intelligence, such that any
machine that can act like a human is displaying AI.36 The ability of
a machine to perform any intellectual task is called Artificial
General Intelligence or Strong AI and is thought to require
a range of skills, such as natural language processing, knowledge
representation, automated reasoning, machine learning, computer
vision and robotics. Each of these skills is the subject of considerable
research in AI, employing different connectionist (ie, data driven) or
symbolic (ie, using logic and symbols) approaches. Recent algorith-
mic advances have enabled profound gains in the performance of
neural networks for machine learning.37 In epidemiology and pub-
lic health surveillance, machine learning is used as one tool to
execute causal inference analysis, diagnosis and prognosis studies,
genome-wide association studies, geospatial applications or
forecasting.38 Such machine learning methods also have the poten-
tial to advance aberration detection.5
POPULATION HEALTH RECORD
The International Organization for Standardization (ISO) has
defined a population health record (PopHR) as a system analogous
to an EHR but containing aggregated and usually deidentified data
for public health and other epidemiological purposes.39 The con-
cept of the PopHRwas subsequently developed further, noting that
its primary purpose is to support efficient and effective public health
practice, that it should be based on an explicit population health
framework and that it should make available indicators that docu-
ment the current status and influences of the health of a defined
population.40 While PopHR systems have yet to be adopted widely
in public health practice, researchers have developed and imple-
mented demonstration systems,33 along with formal ontologies to
support information integration in a PopHR.41
PRECISION PUBLIC HEALTH
Precision public health is inspired by precision medicine with the
idea that a better use of all types of data, encompassing geogra-
phy, physical and sociodemographic characteristics, as well as
health behaviours and biomarkers, at a local or community
scale, would help design specific public health policy for a given
population, and be more effective than general policy.42,43 Some
have argued that the term is problematic, causing confusion with
the precision medicine movement and focusing attention on
individual diagnosis and treatment.44,45 Others have suggested
that precision public health merely rebrands modern public
health surveillance activities and adds little value.45
SECONDARY USE OF DATA
Surveillance activities are relying increasingly on the use of data
not specifically collected for that purpose, including data a priori
not related to health.46,47 The secondary use of data is not new in
surveillance, but it has grown in importance and depth, leading to
a paradigm shift in surveillance. Indeed, the classical approach is
(1) to define or choose the health problem for which surveillance
is necessary, (2) to define and collect the data needed and (3) to
analyse data to address your problem. Along this approach,
‘designed data’ specifically tailored to address surveillance goals
Figure 3 Public health surveillance is a central element of evidence-
based public health. Inspired by Brownson et al 2009.32
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are used. The more contemporary data-driven approach is (1) to
collect data from multiple source without knowing a priori what
will be done with this data and (2) to analyse data to see if they
could help solve surveillance problems. With this approach,
‘organic data’ not specifically tailored for surveillance are used
(see also Big data).48 Designed and organic data have specific
advantages and disadvantages. On the one hand, validity and
reliability of designed data are often documented. Further,
designed data collection processes are defined and the ethical
and legal frameworks for collection are explicit; the lack of
such clear frameworks for organic data is a major current issue
(see also Ethics of public health surveillance and privacy protec-
tion). On the other hand, resources needed to collect designed
data are larger than for organic data. Also, the reporting delay can
be shorter with organic data compared with designed data.
However, the source population of organic data can be tricky to
identify (see also Source population and selectivity bias).31
SOURCE POPULATION AND SELECTIVITY BIAS
Public health surveillance aims to gather information on the
health-related characteristics of a specific population, which
most often is a group of people living in a given location.
More broadly, a population is a group of people sharing
a characteristic, such as a medical condition or treated in
specific healthcare facilities.2,49 With some types of big data,
one difficulty is to define the source population from which
this data have emerged; completeness or representativeness
of the supposedly source population cannot be ensured due
to the non-probabilistic character of this data, resulting
from the selectivity of people from which data are
recorded.50,51 Routinely collected data are often event
based rather than population based, with no information
on the individuals who did not experience the event,46 and
the link between the event and the individual can be diffi-
cult to establish. Further, the source population can change
very rapidly, for example, for sales, online and any other
user-generated data, and in an unpredictable manner. As
a result, denominators cannot be easily computed, and infer-
ence beyond the study population is problematic, due to
a selectivity bias (see also Secondary use of data).
Selectivity bias is a term used to highlight the challenge of
identifying and defining the source population per se of big
data; it differs from selection bias which refers usually to
a sampling issue, making the data used for the analysis
problematic for inference to the source or target population.
SURVEILLANCE BIAS
Many conditions and health-related events under surveillance are
sensitive to the modality and intensity of detection activities, for
example, several types of cancer, thromboembolism or postopera-
tive infections.52,53 Surveillance bias occurs when such conditions
are sought with differential intensity across populations or over
time, or according to care setting and patient characteristics.54,55
As a result, the difference in the frequency (incidence, prevalent) of
the condition may not reflect a change in the risk of this condition,
but instead a difference in the frequency of detection. For instance,
between-hospital differences in the frequency of thromboembolism
following hip surgery can reflect between-hospital differences in
postsurgery screening activities (large number of cases identified in
hospitals with intense screening activities vs low number in other
hospitals), rather than any difference in the quality of care.55
A related concept is the ‘streetlight effect’ which occurs when
surveillance activities are not concentrated on what matters, but
on what is measurable, even if it is not relevant.
SYNDROMIC SURVEILLANCE
Case definitions based on syndromes can enhance the sensitivity
and timeliness of surveillance. Around the turn of the millen-
nium, surveillance of syndromes was implemented on a large
scale by applying automated algorithms to clinical data.56 The
automated detection of syndromes in clinical data and by auto-
mated statistical analysis to detect aberrations in the frequency of
syndromes are defining characteristics of syndromic
surveillance57 (see also Aberration detection). Although an early
motivation for syndromic surveillance was rapid outbreak detec-
tion, the use of non-specific, prediagnostic data can make it
challenging to detect a signal quickly with an acceptable rate of
false alerts.58 Nonetheless, due to their potential to provide real-
time information about population health, syndromic surveil-
lance systems routinely contribute to situational awareness in
many public health systems and are often deployed for mass
gathering events.
CONCLUSION
Data-science and newly accessible data are driving innovation in
methods for public health surveillance and monitoring, offering
new opportunities. However, disappointment is also to be
expected due to the challenge in extracting value from healthcare
data which often lack consistent structure and clear meaning.59
Fostering the ability of primary data providers to improve the
structure and semantics of the data they collect can make it easier
to obtain meaningful information and, eventually, knowledge
from these data. Stronger semantic interoperability between
health information systems35 and more consistent data structure
will be essential to help moving from big to smart data, that is,
data that can be used to produce information, and to transform
health systems which are currently data rich but information
poor into systems which are data and information rich.60
Finally, while many resources are directed towards data collec-
tion and processing, the resources and expertise needed to make
these data truly useful for surveillance, namely background
knowledge on public health and on the processes generating the
data,6 are critical more than ever in an age of data science;
knowledge brokers are needed to bridge data science, health
monitoring and public health.
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